Michele Rasamoelisolo

Title: Michele Rasamoelisolo: Innovator in Anti-Angiogenic Peptides

Introduction

Michele Rasamoelisolo is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of anti-angiogenic peptides. With a total of 2 patents, his work has the potential to impact medical treatments significantly.

Latest Patents

Michele's latest patents focus on long-lasting anti-angiogenic peptides. These modified peptides are capable of forming a peptidase-stabilized anti-angiogenic peptide. Specifically, the modified kringle 5 peptides can form a conjugate with a blood protein. The conjugates are prepared by combining the peptide with a reactive functional group and a blood protein. These conjugates can be formed either in vivo or ex vivo and are administered to patients to provide an anti-angiogenic effect.

Career Highlights

Throughout his career, Michele has worked with several companies, including Conjuchem Biotechnologies Inc. and Conjuchem, Inc. His experience in these organizations has allowed him to refine his expertise in biotechnology and peptide development.

Collaborations

Michele has collaborated with various professionals in his field, including Karen Thibaudeau and Xicai Huang. These collaborations have contributed to the advancement of his research and innovations.

Conclusion

Michele Rasamoelisolo is a pioneering inventor whose work in anti-angiogenic peptides holds promise for future medical applications. His contributions to biotechnology continue to pave the way for innovative treatments.